Tweets
-
Severe weather – Information on its impact on biological products: http://1.usa.gov/m8aeEF .
-
To see the list of guidance topics
#CBER is considering for development during 2013, visit http://1.usa.gov/w0Z4rn . -
Follow
#CBER Human Cell & Tissue Product (HCT/P) compliance inspection statistics at http://1.usa.gov/WMsBrs . -
FDA Consumer Update- Beware of Fraudulent Flu Products. For more information, go to: http://go.usa.gov/4Q8H
-
#CBER announces the 02/27/13 VRBPAC Mtg to discuss the virus strains to be included in the 2013-2014 Influenza vaccine http://1.usa.gov/127k06j -
#CBER announces the February 12, 2013 Blood Products Advisory Committee Meeting. Details can be found at http://1.usa.gov/UohBQo -
#FDA approves Flublok, a new seasonal influenza vaccine made using novel technology. http://1.usa.gov/XEDTN4 -
Check out FDA's official blog (FDA VOICE) for information on Flu Vaccine availability: http://1.usa.gov/v7V0zb
-
REMINDER: The Cellular, Tissue and Gene Therapies Advisory Committee Meeting will be held on January 15, 2013 http://1.usa.gov/VEzzu4
-
#CBER announces approval of Bivigam (IGIV, Human), 10% Liquid) for treatment of primary humoral immunodeficiency (PI) http://1.usa.gov/VCmlxN -
#CBER approves VARIZIG for post-exposure prophylaxis of varicella in high risk individuals http://1.usa.gov/YgpS76 -
#CBER FY 2012 “Report from the Director” is now posted on#FDA’s website - http://1.usa.gov/UMGoLo . -
#CBER announces the approval of Fluarix Quadrivalent (Influenza Virus Vaccine) http://www.fda.gov/BiologicsBloodVaccines/ucm332623.htm … -
Announcing the Cellular, Tissue and Gene Therapies Advisory Committee Meeting to be held on January 15, 2013 http://1.usa.gov/VEzzu4
-
#CBER approves EVARREST - fibrin sealant patch http://1.usa.gov/11TaGRR -
Computerized data mining system designed to speed identification of adverse events following vaccinations http://1.usa.gov/YvdIwQ
-
Announcing the next Blood Products Advisory Committee (BPAC) Meeting to be held 12/4/2012 and12/5/2012 http://1.usa.gov/V4MUxJ
-
#FDA Science & Research: Firefly Chemistry Used to Evaluate Tuberculosis Vaccines http://1.usa.gov/UMQqN4 -
#FDA approves first seasonal influenza vaccine (Flucelvax) manufactured using cell culture technology http://1.usa.gov/TjaGI3 -
Guidance for Industry: Use of NAT on Pooled & Individual Samples to Reduce the Risk of Transmission of Hep B Virus http://1.usa.gov/S8ewma
FDA CBER
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.